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ABSTRACT 
The aims of this study were to investigate: (i) the level of knowledge and attitudes to 
sexual ity and sexually transmitted diseases in young women, (ii) to relate these data to 
actual life-style and sexual behaviour, and (iii) to estimate the spread of sexually 
transmitted diseases (STD) in young women in relation to their sexual behaviour. In 
Paper I the knowledge and attitudes to STD and STD prevention were studied by a 
questionnaire in 18-19 year old students during a school lesson. Girls were found to be 
better informed than boys and the level of knowledge increased from 1986 to 1988, 
probably due to greater national attention to these problems. Paper II describes in a 
longitudinal 2 year study, the association between knowledge, attitudes and behaviour 
among 16-18 year old girls and demonstrates that a high level of knowledge not 
necessarily leads to adequate behaviour. Paper III emanates from the same group of 16-
18 year old girls and compares life-style factors and continued sexual behaviour in 
relation to age of coitarche. An early coitarche was associated with an early menarche, 
big families and an early move from the parental home. Girls with an early coitarche 
had a more risky behaviour and had more STD:s and cervical atypias. In paper IV, 
women <25 year old coming for contraception advice were evaluated regarding cervical 
chlamydia trachomatis infection and cytological atypias. Twelve percent of the 
screened population were found to have a chlamydia infection and 3 % had koilocytosis. 
Those with a positive test for chlamydia infection were followed for 15 months. During 
the follow up 27/32 women cumulatively had clinical or subclinical signs suggesting 
a genital papillomavirus infection and at the last visit 6/32 had an atypia. Paper VI 
describes the prevalence of HPV DNA in the cervix in 16 year old girls followed for 
2 years, and shows no HPV DNA in virgins but a quick increase in cervical HPV DNA 
after coitarche and that occurrence was related to the number of sexual partners. Paper 
VI refers to the same girls and relates the occurrence of serum-antibodies against 
HPV16 and HPV33 to the existence of HPV DNA in the cervix. No virginal girl had 
antibodies and the correspondence between HPV 16 antibodies and cervical HPV DNA 
was good. In paper VII the presence of antibodies against HSV-1, HSV-2, EBV and 
CMV in serum among the group of 16-18 year old girls was studied and it was 
concluded that the prevalence of antibodies against HSV-1 and EBV was significantly 
higher among sexually experienced girls. 
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ABSTRACT 
The aims of this study were to investigate: (i) the level of knowledge and attitudes 
to sexuality and sexually transmitted diseases inyoung women, (ii) to relate these 
data to actual life-style and sexual behaviour, and (iii) to estimate the spread of 
sexually transmitted diseases (STD) in young women in relation to their sexual 
behaviour. In Paper I the knowledge and attitudes to STD and STD prevention 
were studied by a questionnaire in 18-19 year old students during a school lesson. 
Girls were found to be better informed than boys and the level of knowledge 
increased from 1986 to 1988, probably due to greater national attention to these 
problems. Paper II describes in a longitudinal 2 year study, the association 
between knowledge, attitudes and behaviour among 16-18 year old girls and 
demonstrates that a high level of knowledge not necessarily leads to adequate 
behaviour. Paper III emanates from the same group of 16-18 year old girls and 
compares life-style factors and continued sexual behaviour in relation to age of 
coitarche. An early coitarche was associated with an early menarche, big 
families and an early move from the parental home. Girls with an early coitarche 
had a more risky behaviour and had more STD:s and cervical atypias. In paper 
IV, women <25 year old coming for contraception advice were evaluated 
regarding cervical chlamydia trachomatis infection and cytological atypias. 
Twelve percent of the screened population were found to have a chlamydia 
infection and 3% had koilocytosis. Those with a positive test for chlamydia 
infection were followed for 15 months. During the follow up 27/32 women 
cumulatively had clinical or subclinical signs suggesting a genital papillomavirus 
infection and at the last visit 6/32 had an atypia. Paper VI describes the 
prevalence of HPV DNA in the cervix in 16 years old girls followed for 2 years, 
and shows no HPV DNA in virgins but a quick increase in cervical HPV DNA 
after coitarche and that occurrence was related to the number of sexual partners. 
Paper VI refers to the same girls and relates the occurrence of serum-antibodies 
against HPV16 and HPV33 to the existence of HPV DNA in the cervix. No 
virginal girl had antibodies and the correspondence between HPV 16 antibodies 
and cervical HPV DNA was good. In paper VII the presence of antibodies 
against HSV-1, HSV-2, EBV and CMV in serum among the group of 16-18 year 
old girls was studied and it was concluded that the prevalence of antibodies 
against HSV-1 and EBV was significantly higher among sexually experienced 
girls. 
Key words: adolescence; sexual behaviour; sexually transmitted diseases; 
knowledge and attitudes; coitarche; contraception; reproductive health; Chlamydia 
trachomatis; Herpes simplex virus; Epstein-Barr virus; Cytomegalovirus; Human 
papillomavirus; epidemiology; serology. 
ISBN 91-628-1914-3 
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ABBREVIATIONS 
AIDS : Acquired immunodeficiency disease syndrome 
ASCUS: Atypical squamous cells of undetermined significance 
CIN : Cervical intraepithelial neoplasia 
CMV: Cytomegalovirus 
CT: Chlamydia trachomatis infection 
CTP: Chlamydiatrachomatis positive 
DFA: Direct fluorescence antibody test 
EBV: Epstein-Barr virus 
ELISA: Enzyme-linked immunosorbent assay 
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HSV : Herpes simplex virus 
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OC: Oral contraceptives 
RR: Relative risk 
P3HR-1 : An Epstein-Barr virus-carrying Burkitt lymphoma cell line 
PCR: Polymerase chain reaction 
SQ: School questionnaire group (paper I) 
STD: Sexually transmitted disease 
VCA: Virus capsid antigen 
VAS: Visual analouge scale 
9 
1. INTRODUCTION 
1.1 Reproductive health 
On a global level reproductive behaviour is an important health parameter, 
influencing both mortality and morbidity (Piot & Islam 1994). This is especially 
obvious today when the world-wide dissemination of the human immunodefic iency 
virus (HIV) threatens to wipe out whole populations. In addition, maternal 
mortality, and illness and death linked to illegal abortions, is still a problem of 
considerable dignity in many parts of the world (Bergström 1993). 
The situation in Sweden is, however, more favourable. Maternal mortality 
is almost overcome, and appropriate legislation on abortion makes this procedure 
safe. HIV is s till a rather uncommon infection, and infected children and 
teenagers are rare. The majority of our problems relate to other sexually 
transmitted infections such as chlamydia trachomatis, which affects fertility, 
human papillomavirus infections which causes cervical intraepithelial neoplasia, 
and herpes viruses which may seriously threaten the fetus and the new-born 
baby. There are also important psychological problems connected to reproductive 
health, influencing the identification process and well-being. Unconscious 
desires tend to inhibit logical thinking with regard to sexuality and make risk-
taking behaviour more prevalent. 
1.2 Adolescence 
Several developmental issues are pertinent to adolescents (Elkind 1978), including 
psychosexual maturation, the development of hypothetical reasoning and 
conditions relating to risk-taking behaviour. Cates (1991), as well as Biro & 
Rosenthal ( 1992), have described this process regarding sexuality and sexually 
transmitted diseases. During early adolescense a transition in cognitive 
development from concrete operational to formal operational thinking enables 
the adolescent to use hypothetical reasoning. Formal operational thinking is 
believed to solidify at approximately 14 years of age but many adolescents may 
reach formal operational thinking at a later age. Hypothetical reasoning ability 
can be task-dependent and may for instance be less frequently applied to sexual 
behaviour than to school exercises. The onset of formal operational thinking 
produces egocentrism or self-centred thinking including the belief that natural 
laws do not apply to oneself ("personal fable"). There is also a tendency for 
adolescents to place him or herself in the centre of things surrounded by an 
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"imaginary audience", focusing attention on themselves. Volitional risk-tak ing 
behaviour has positive as well as negative effects and meets developmental 
needs. Sexual activity in adolescence may meet developmental needs such as 
autonomy, affiliation and identity (Irwin 1990). Protecting oneself from STD 
may be in conflict with meeting these developmental needs and these "costs" will 
exceed the current advantages. 
1.3 Teenage sexuality 
Reliable contraceptives have contributed to the acceptance of premarital and 
teenage sexuality. Age of coitarche differs in different countries due to cultural 
factors (Jones et al 1985). In Sweden the median age for sexual debut is some 
years earlier than in other European and American countries. In a large study 
among 15-25 year old women visiting family planning clinics in Gothenburg in 
1988, the median age of coitarche was 16.5 years and 90% ofthe women had had 
their first coitus by 19 years of age (Ramstedt et al 1992). Riphagen & von 
Schultz (1989) and Gisecke et al (1992) have reported similar figures. The 
median age of female coitarche appears to have decreased by 2 years during the 
last 25 years (Zetterberg 1969; Klanger et al 1993), and probably has reached 
a steady state during the last decade. Nowadays girls tend to have their first 
intercourse at a younger age than boys (Gisecke et al 1992; Persson et al 1992a; 
Sundet et al 1992). Kontula & Haavio-Mannila ( 1994) found similar tendencies 
in Finland during the past few decades. In Denmark the age for coitarche 
corresponds to the Swedish figures (Wielandt & Boldsen 1989), in Norway the 
age for coitarche is a little higher (Kraft 1991; Sundet et al 1992). An early 
coitarche has been reported to be associated with continued risk behaviour 
(Greenberg et al 1992; Seidman et al 1994). 
1.4 Sex education 
Sweden was the first country in the world to establish compulsory sex education 
in its schools. The curriculum involves all grades and pays attention to 
contraception and the discussion of human and sexual relationships. Policy is 
based on the principle that attitudes are changed more effectively with opennes  
and knowledge rather than with threats, edicts and repression (Sundström-
Feigenberg 1988). In the spring of 1986 the Swedish National Board of 
Education requested schools to introduce teaching about HIV/AIDS and other 
sexually transmitted diseases (STD). During the following years information 
campaigns funded by the Swedish National Commission on AIDS have been 
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instigated and the media have drawn attention to the risks. Surveys in Sweden 
have shown widespread and good knowledge about STD and STD protection 
(Persson & Jarlbro 1992b). Brorsson & Herlitz (1988) found changes in 
knowledge and attitudes going on in Sweden, as well as Kegeles et al ( 1988) and 
Zimet et al ( 1993 ) did in the US A. Contrary to other studies questioning the use 
of appropriate behaviour (Tydén et al 1991 a; Di demente et al 1993), Brorsson 
& Herlitz (1988) also reported changes in behaviour. 
1.5 Contraception 
Ever since oral contraception was introduced in the sixties, it has been the most 
used contraceptive method for teenagers in Sweden (Andersch & Milsom 1982; 
Brännström et al 1991; Milsom et al 1991; Larsson et al 1996). Changes in 
sexual habits and the transition from the use of condoms to the use of OCs 
assisted the transmission of genital infections. A substantial increase in gonorrhoea 
in the early seventies lead to campaigns to persuade people to use condoms. The 
discovery ofthe human immunodeficiency virus together with the high prevalence 
of chlamydia trachomatis infections led to new campaigns. 
Several studies have indicated an increased use of condoms by young people 
(Tydén et al 1996; Larsson et al 1996). However, condoms are not always well 
accepted by teenagers, and an inconsistent use of condoms is reported to be a 
common phenomenon (Traeen 1994). Oral contraceptives have now been used 
for more than 30 years and several studies (Andersch & Milsom 1982; Milsom 
et al 1991; Larsson et al 1996) have described the connection between the 
womans' opinion of the possible health hazards of OC and its influence on 
compliance. In some countries even a female type of a condom has been 
introduced (Editorial 1993), but not in Sweden. 
1.6 Sexually transmitted diseases, epidemiology 
The annual number of gonorrhoea infections in Sweden declined from 40 000 in 
1970 to 33 8 in 1994, probably due to efficient treatment and an effective contact 
tracing organization (Ramstedt et al 1985). It became possible to diagnose 
genital chlamydia trachomatis infections in the late seventies. Some parts of 
Sweden were quick to initiate testing. However, the county ofVärmland, where 
this study was performed, began testing first in the middle of the eighties. Studies 
carried out in Family Planning Centres and Youth Clinics from various places 
in Sweden have reported prevalences of 10-20% in sexually active young women 
in the eighties (Örtqvist et al 1984; Rahm et al 1988). In Karlstad the 
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corresponding figures for women less than 25 years age were 11% in 1986-88 
compared to 3% in 1990-1991. (Andersson-Ellström 1993). The decreasing 
prevalence was seen to coincide with the inclusion of chlamydia trachomatis 
infection in the Swedish STD-legislation, facilitating a better control of contact 
tracing. The age-specific rates of PID are highest for adolescents if appropriate 
adjustments are made for sexual activity (Bell & Holmes 1984; Weström 1980; 
Lidegaard & Helm 1990). 
In spite ofthe declining prevalence ofbacterial STD:s, sexually transmitted 
viral infections are still common (Evander et al 1995), indicating that the 
decrease in chlamydial infections for the most part was due to better diagnostics, 
contact tracing and treatment. 
Human papillomavirus infection has been estimated to be the most common 
sexually transmitted disease in the Western world (von Krogh 1991). HPV is 
viewed as the primary cause of most cases of cervical intraepithelial neoplasia 
(Schiffman et al 1993) and is an important causal factor in most cases of cervical 
cancer (Munoz et al 1992). During the last few years non-sexual pathways for 
the transmission of genital HPV have been suggested (Sedlacec et al 1989; 
Jenison et al 1990; Pao et al 1993). A high prevalence of serum antibodies against 
various HPV 16-derived antigens among healthy children (Jenison et al 1990) has 
been taken as evidence of prevalent non-sexual transmission ofHPV 16. However, 
Fairley et al ( 1992) and Ry lander et al ( 1994) found no HPV 16 in virginal girls, 
and several major studies found a close connection between genital HPV 
occurrence and sexual activity indicating that the major route of transmission is 
the sexual one (Ley et al 1991; Schneider & Koutsky 1992; Bauer et al 1993; 
Hildesheim et al 1993; Wheeler et al 1993). Common cancer-associated high-
risk genitoanal HPV-types are types 16and 18.HPVtypes 31,33,35,39,45, 
51, 52 56 and 58 are also found in cancers. HPV types 6 and 11 are only very 
rarely found in cervical cancers (Lörincz 1992, Bosch 1995). Additional 
genitoanal types exist but have not been well characterized. 
The Herpes group viruses, herpes simplex virus type 1 (HSV-1), HSV-2, 
cytomegalovirus (CMV) and Epstein-Barr virus (EBV), al 1 have the characteristic 
ability to establish latency and are intermittently reactivated in the human host. 
Most infections are asymptomatic and the majority of the population acquires 
antibodies against both HSV, CMV and EBV. HSV-2 is predominantly sexually 
transmitted and HSV-1, EBV and CMV can also be identified in the genital 
mucosa (Gibson et al 1990; Sixbeyetal 1986;Näheretal 1992;Ho 1990). HSV-
2 has speculatively been suggested to play a role in the development of cancer 
as a contributing factor in the development of carcinoma of the cervix uteri 
(Rawls et al 1980; Rapp 1989). EBV is regularly associated with Burkitts 
lymforna and nasopharyngeal carcinoma (Zur Hausen et al 1970; Nonoyama et 
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al 1973). The spread of the herpes group viruses has in a global and historical 
view been connected to socioeconomic conditions (Evans et al 1989; Nahmias 
et al 1990; Ho 1990). HIV infections are still rare in Sweden, but a further 260 
persons were found to be HIV positive in 1994. Only a few of them were 
teenagers. 
1.7 Development of new diagnostic techniques 
1.7.1 Direct tests 
Chlamydia trachomatis: Culture has been the "golden standard" for diagnosis, 
due to a 100% specificity. The sensitivity, however, is rather low, reported to be 
between 3 8-100%, and dependent on the specimen collection method, cell culture 
technique and the period of time since sampling, etc. (Kellog 1989). Other, less 
labour intensive tests, became available in the eighties'. Enzyme linked 
Immunoassay (EIA) is a simple analysis procedure and samples can be tested 
several days after sampling. The EIA test produced by Abbot (Chlamydiazyme, 
USA) has shown a rather good specificity (Lefebvre et al 1988; Svensson et al 
1991) and a varying sensitivity from 75-95 % (Baselski et al 1987; Lefebvre et 
al 1988; Svensson et al 1991). To increase specificity, the EIA test is often 
verified by a direct fluorescence antibody test (DFA). By using the EIA as a 
screening method and DFA as a verification, one attains a less expensive and less 
labour-intensive method giving a sensitivity of 91% and by definition a 100% 
specificity (Svensson et al 1991 ). The current introduction of the PCR technique 
for chlamydial testing will probably further increase diagnostic reliability (de 
Barbeyrac et al 1994). 
Human papilloma virus: Clinical signs of warts, colposcopic exam ination with 
acetic acid painting, and microscopical morphological examination for 
koilocytosis, were the only means of HPV diagnosis until the DNA detection 
methods became established. Koilocytosis is considered to be pathognomic of 
HPV infection (Meiseis 1983 ; Schneider & Koutsky 1992). Colposcopy has a 
good sensitivity (Schneider et al 1988; Spitzer et al 1990) but the specificity of 
m inor morphological abnormalities for the detection of subclinical HPV infection 
appears to be low (Schneider & Koutsky 1992). The most sensitive DNA 
detection method is the polymerase chain reaction (PCR) technique which 
requires only small fragments of the DNA chains. By using the thermo-stable 
enzyme Taq polymerase and specific primers, small amounts of HP V DNA can 
be multiplied by repetitive cycles of heat alterations. An alternative, somewhat 
less expensive and less sensitive hybrid capture human papillomavirus DNA 
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detection test has been launched commercially (Sun et al 1995). 
Herpes viruses: In addition to virus isolation, DFA tests for herpes simplex 
viruses have been established. These tests are not impaired by long transport 
distances, but require puncture of intact blisters. 
1.7.2 Serological tests 
Antibodies: The development of more specific serological tests, often using 
ELISA techniques, makes it possible to determine different types of the same 
virus, e.g. HSV-1 can be differentiated from HSV-2 (Svennerholm et al 1984), 
and genital chlamydial infections from other types of chlamydial infections 
(Treharne et al 1977). Recently, ELISA tests, that measure type-specific 
infection with human papillomavirus have been developed (Dillner 1995). 
Antibodies against HPV 16 capsids (Kirnbauer et al 1994) and HPV3 3 capsids 
(Andersson-Ellström et al 1994) have shown association with HPV DNA 
detectability and sexual behaviour. 
2. AIMS OF THE STUDY 
(i) To assess knowledge about STD and STD prevention among teenagers 
at the time close to their sexual debut. 
(ii) To investigate the relationship between young girls ' knowledge about 
STD and STD prevention, and their own sexual behaviour. 
(Hi) To study the association between biological, familial and social factors 
and the age of sexual debut, and to investigate continued risk behaviour 
in relation to age of sexual debut. 
(iv) TostudytheprevalenceofcervicalChlamydiatrachomatis (CT) infections 
in young women visiting contraception clinics, and longitudinally re­
examine chlamydia-positive women for 1 year regarding reinfections 
with CT or signs of human papillomavirus infections and cervical 
intraepithelial neoplasias. 
(v) To study the prevalence and incidence of different types ofHPV-DNA in 
the cervix and relate the occurrence to sexuality. 
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(vi) To study the prevalence and incidence of serum antibodies to 
papillomaviruses and herpesviruses. 
(vii) To relate the prevalence of serum antibodies against human 
papillomaviruses to the occurrence of HPV DNA in the cervix and to 
sexuality. 
3. MATERIAL 
This thesis is based on studies in 3 groups, which investigate: 1)18-19 year old 
male and female students (I); 2) women younger than 25 years of age (IV); and 
finally 3)15-17 year old girls followed longitudinally for 2 years (II; III; V; VI; 
VII). 
3.1 Paper I describes a study in 953,18-19 year old boys and girls, completing 
their education in theoretical or practical upper secondary schools in Karlstad 
(a middle-sized Swedish city, 80.000 inhabitants) or in Torsby (a small town in 
the same county) in May 1986 or in May 1988 (referred to as the school 
questionnaire group - SQ.) 
3.2 Paper IV describes a study in 323 women, <25 years, who visited the Gripen 
Family Planning Clinic orthe Youth Clinic, Karlstad, between September 1986 
and February 1987. Two hundred and ninety eight women had experience of 
coitus (the FPYC group). The median ageofthewomen was 19 years (range 13-
24), 55% being in the interval of 16-19 years, 4% were younger than 16 years. 
From this group of298 women with coital experience, 32 of the 36 Chlamydia-
positive women (median age 19, range 16-24) were followed for a median time 
of 15 months (range 9-22). These women will be referred to as the chlamydia 
trachomatis positive (CTP) group. 
3.3 Papers II, III, V, VI and VII: All 168 girls younger than 18 years, starting 
their education in the health care program of an upper secondary school in 
Karlstad between September 1989 and September 1990, were invited to participate 
in a study about sexuality and sexually transmitted diseases. The 98 girls who 
accepted to participate (6 girls 15 years old, 78 girls 16, and 14 girls 17) were 
followed for 2 years. (Referred to as the healthy school girls - HSG, and when 
entering the study referred to as "16".) 
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4. METHODS 
4.1 Design of the studies 
4.1.1 The first study (I) took place in the class-room, where all pupils, without 
any preceding announcement, were given a questionnaire to complete during a 
lesson. The questionnaire comprised 19 multiple-choice and 3 open-ended 
questions, testing knowledge and attitudes about sexuality and sexually transm itted 
diseases. In 198 8 an additional 1, open-ended question was added, evaluating the 
best sources ofinformation. 
There were no non-responders: All students answered the questionnaires, 
some of them passing over a few questions, as described in paper I. 
4.1.2 The second study (IV) emanates from the family planning clinic and the 
youth clinic where women < 25 years, coming to a midwife for advice on 
contraception, were screened for cervical chlamydial infection (CT). The 
diagnosis was made by an enzyme immunoassay test (EIA, Chlamydiazyme, 
Abbot, USA) confirmed by a direct immunofluorescence test (DFA, MicroTrac, 
Syva, USA), as described below. The women were also screened for cytological 
changes by means of a Papanicolaou (PAP) smear, also described below. A face-
to-face interview supplemented the investigation. Chlamydia-positive women 
(CTP), (median age 19 years, range 16-24) were followed by the author for 3 
visits: before treatment, one month later, and one year after treatment. Atthe first 
visit, cultures for gonorrhoea were taken and colposcopy with acetic acid testing 
was performed. Treatment for the chlamydia trachomatis infection was given at 
the first visit with 200 mg doxycyklin followed by 100 mg for 8 days, and 
contacts were traced and treated (independent of the result of the test, if it was 
a steady partner). At follow-ups, cervical swabs for EIA and DFA were taken. 
At the first and third visit, colposcopy was performed and at the third visit 
another PAP-smear was taken. Biopsies were taken in some cases where 
colposcopic criteria indicated CIN or GPVI. No analysis has been performed on 
the 12 non-responders (4%). 
4.1.3 The third study is a longitudinal study, performed on healthy schoolgirls 
(II; III; V; VI; VII), and comprising 2 years of gynecological health control and 
the possibility of contraceptive advice. The invitation was given by the author 
who visited the class-room, described the investigation, and asked girls to fill in 
a paper whether they wanted to participate in the study or not. Those who 
accepted to participate were called to the Youth Clinic every 6 months for a 
structured face-to-face interview. A total of 5 visits were made. At the first and 
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last visit the girls answered a self-administrated questionnaire about family 
situation, sexuality, knowledge and attitudes to contraceptives and STD. At 
every visit a blood sample was taken for serological tests. Twice, at the first or 
second visit, and at the last visit, a gynecological examination was performed and 
samples from the cervix were taken for cytology, chlamydia- and HPV-DNA 
direct tests in the same sequence as below. Girls were told to come for a virus 
isolation sample if genital blisters became apparent. The study was approved by 
the Ethics Committee, Örebro. Parents were informed about the study in 
meetings at school before the start of the study. In order to respect the integrity 
of the girls not choosing to participate, we have not performed any analysis of 
the non-responders (42%). 
4.2 Diagnostic methods 
4.2.1 Interview: All interviews were carried out according to a standardized 
questionnaire (II; III; IV; V; VI; VII). The questions were given in a similar and 
neutral way to all participants. Questions about sexual behaviour were limited 
to participants who reported sexual experience. 
4.2.2 Questionnaires: The questionnaires comprised multiple choice and open-
ended questions as mentioned above (I; II; III). In the questionnaires, testing 
knowledge and attitudes (I; II) a "don't know" alternative was added, to decrease 
guesswork. The healthy school girls (III) were also requested to complete some 
visual analouge scales (VAS). The technique involves making a mark on a 10 
centimetre long line, and the distance from the left end of the line to the indicated 
point was measured to describe their appreciation of themselves, their relationships 
to their families and friends, their mood and their worries about reproductive 
health. 
4.2.3 Direct tests : The enzyme immunoassay tests for chlamydia trachomatis 
(Chlamydiazyme, Abbot, U SA) were analysed at the Microbiological laboratory 
of the Central Hospital in Karlstad. To verify a positive or uncertain 
Chlamydiazyme test a direct fluorescence antibody test (Microtrac, Syva, U SA) 
was used. Cultures for Neisseria gonorrhoe were performed using a modified 
Stuart transport medium (Gästrin & Kallings 1968) and tested in the for 
Scandinavia standardized way (Wilkinson 1977) at the Microbiological Clinic 
in Karlstad. For the analysis of human papillomavirus deoxyribonucleic acid 
(HPV-DNA), samples from the cervix were taken with a Cytobrush (Medscand, 
Sweden) and put in a test tube containing 96% ethanol for subsequent analysis 
with the polymerase chain reaction (PCR) method performed at the Stockholm 
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Central Microbiology Laboratory as described by Skyldberg et al in 1991. DNA 
sterility was observed throughout. Detection and typing of HPV DNA was 
performed by using the degenerated consensus-primer My 09-11 according to 
Manos and coworkers (1989) and type-specific HPV-primers(type 6/11,16,18, 
31, 33). The procedure has been described in detail by Skyldberg et al 1995. 
HLA primers were used to check the adequacy of DNA extracted from the 
cytological samples by a routine procedure (Erlich & Bugawan 1989). 
Papanicolau smears were analysed at the Cytological laboratory of the Central 
Hospital in Karlstad. A re-screening of PAP-smears to determine the occurence 
of koilocytosis was performed on all 284 samples from the second study (IV) at 
the Cytology laboratory, Sahlgrenska University Hospital, Gothenburg by one 
investigator who had no access to the results of clinical examinations or previous 
cytological diagnosis. All positive samples from the third study (V) were re­
evaluated by Björn Hagmar, Rikshospitalet, Oslo University. 
4.2.4 Colposcopy: The colposcopic examination included a test with 5% acetic 
acid and was performed using the criteria described by Schneider et al in 1988. 
4.2.5 Serological tests: The serological tests for herpes viruses (HSV-1, HSV-
2, CMV, EBV) were evaluated at the Microbiological Clinic, Sahlgrenska 
University Hospital, Göteborg. HPV serology was evaluated at the Microbiology 
and Tumorbiology Center, Karolinska Institute, Stockholm. 
Herpes simplex virus: Serum was assayed in a direct enzyme-linked 
immunosorbent assay (ELIS A), using a HSV type common antigen, containing 
envelope glycoproteins (Jeansson et al 1983) and the HSV-2 type-specific 
glycoprotein G (gG-2) antigen (Svennerholm et al 1984). Microtiter plates 
(NUNC Immunopiates, Denmark), coated with antigen, were incubated with 
serum samples in serial two dilutions starting at 1:100. For detection, horse­
radish peroxidase conjugated antihuman IgG (Jackson USA) was used. By this 
method, antibodies against HSV-2 and indirectly against HSV-1, can be 
evaluated. Samples positive against HSV-type common antigen, which were gG-
2-negative were regarded as HSV-1 positive. On the other hand, the procedure 
precluded reliable determination of HSV-1 -positivity if HSV-2 antibodies were 
present. 
Cytomegalovirus: Antibodies against CMV were determined by an ELI S A-test 
described by Krishna et al (1984), using the same microtiter plates and horse­
radish peroxidase conjugated antihuman IgG as described for the detection of 
HSV antibodies. 
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Epstein-Barr virus: EBV specific IgG antibodies to the virus capsid antigen 
(VCA) were demonstrated according to standard procedures by incubation of 
serial two-fold dilutions of sera on P3HR-1 cells in indirect immunofluorescence 
(Lennette 1988). 
Human papillomavirus: By using ELISA tests, serum samples were tested for 
reactivity with baculovirus-expressed capsids of HPV 16 (Kirnbauer et al 1994) 
and HPV33 (Volpers et al 1994). Disassembled similarly prepared Bovine 
Papillomavirus capsids were used as negative control, to distinguish between 
type-specific and cross-reactive HPV antibodies. 
4.3 Statistical analysis 
Distributions between groups were compared with the Chi-square test or 
Fisher's exact test. Comparisons of mean values between 2 groups were 
performed using Student's t-test. Duncan's multiple range test was used to 
compare mean values between 3 or more groups simultaneously. 
5. RESULTS 
5.1 Study populations 
All 953 invited SQ students answered the questionnaire (I). More than 98% 
answered at least 17 of the 19 multiple choice questions and more than 90 % 
answered the remaining 2 multiple-choice questions. Only 2 open-ended questions, 
concerning where to seek advice and the reasons for controlling STDs caused 
major default. 
Three hundred and twenty three of the women who underwent gynecological 
examination (96.4%) agreed to participate in the second survey (IV). Coital 
experience was reported by 298 women and they comprise the study group 
(FPYC). Thirty two of the 36 CT positive women (CTP) were followed for a 
mean of 15 months. 
One hundred and sixty eight girls started their upper secondary school 
education in the health care programme course and were invited to participate in 
a 2 year longitudinal study (II; III; V; VI; VII). Ninety-eight girls (5 8%) accepted 
the invitation to participate, 95 came for a second visit and 89 completed the fifth 
visit of the study. However, complete data is only available for 88 girls. There 
were no significant differences between girls who dropped out of the study and 
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the girls who completed the study with respectto age, socioeconomic background, 
age of coitarche, number of coitus partners and use of contraceptives at the age 
of 16. In order to respect the integrity of the girls refusing to participate, we did 
not investigate this group. 
5.2 Sexuality 
5.2.1 Median age for coitarche was 16 years, both in the cohort of women 
visiting the family planning clinic or the youth clinic (FPYC) in 1986-87 (IV), 
and in the cohort of healthy school girls (HSG) in 1989-90 (III). Eighteen women 
(6%) in the FPYC group reported coitarche before the age of 14, compared to 
8 (8%) in the HSG group; 244 (82%) reported coitarche before the age of 18 in 
the FPYC group compared to 72 (81%) in the HSG group. In the 18-19 years 
old SQ group from 1988, 79% of the girls and 75% of the boys had coital 
experience (I). In 1986 more girls in the practical courses compared to girls in 
the theoretical courses had had their sexual debut (p<0.01 ). Two years later, the 
difference was less pronounced. In 1988 more girls living in the rural area had 
experience of coitus compared to girls from the city (pO.Ol). Healthy school 
girls (HSG) with coitarche before the age of 15 years had more frequently had 
their menarche before the age of 13 (p<0.05) (III). 
5.2.2 Number of partners. In the group of sexually experienced healthy school 
girls (II; III : V; VI; VII) the mean number of coitus partners at the age of 18 was 
3.9 and the median number 3 (range 1 -27). Two girls (3%) reported more than 
10 life-time partners. 
The number of partners was evaluated among the 16-24 years old chlamydia-
positive (CTP) women (mean and median ages were 19 years) in the FPYC (IV). 
Fiveof31 responders ( 17%) reported 1 life-time coital partner, 17responders 
(55%) reported 2-4 partners, 6 responders (19%) 5-10 partners and 3 (10%) 
more than 10 life-time partners. 
5.2.3 Steady partner: In the FPY C group, 249 of298 women (83.5%) reported 
a steady sex partner according to the woman's own definition (IV). The sexually 
experienced healthy school girls reported a steady sex partner in 64-77% during 
2 years of follow-up and in an increasing degree when getting older (II; III; V; 
VI; VII). Seven of the 54 girls with more than 2 years of coitus experience 
reported the same steady partner during the 2 year follow-up period. 
5.2.4 Sexual activity: Teenage girls with an early coitarche were sexually more 
active during the observation period than the girls were who reported a later 
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coitarche (III). Girls were in general sexually more active at the age of 18 
compared to the age of 16. Three of 4 girls, independent of the age for coitarche, 
had their second coitus within 6 months of their debut but there was a tendency 
to fewer early debutating girls having their second coitus in less than 1 month 
after the debut. 
Unprotected coitus 
Group 
Consistent condom use 
Fig. 1. Results from each visit during the study in the three groups of girls with coitus 
experience (Group A = sex debut <15 years; Group B1 = sex debut >15 years, but 
before entering the study; Group B2 = sex debut >15 years but after entering the 
study).Upper left: Percentage distribution of girls with no coitus experience last 
month; Upper right: Percentage distribution of girls with unprotected coitus last 
month; Lower left: Percentage distribution of consistent condom use during last 
month; Lower right: Percentage distribution of use of oral contraception last month. 
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5.3 Contraception 
5.3.1 Choice of methods: At the age of 18, 93% of the sexually experienced 
healthy school girls reported experience of OC, and 41 of 53 girls reporting 
coitus during the last month had then used OC for contraception at that time 
(77%) (II). Experience of condom use was reported by 89%, of whom 71% had 
adopted this method during the last year. Only 7 of 53 girls (13%) reporting 
coitus the last month, had used a condom at that time. Current condom users often 
tended to report occasions of unprotected coitus during the last month, both at 
the age of 16 and 18. At the final visit (at 18 years of age) only 4 girls (6%) 
reported a latest coitus with OC supplemented by a condom. In the FPYC group 
64% of the women were using OC (IV). 
5.3.2 Changes over time: The intention to use a condom increased among 18-
19 years old students in 1988 compared to 1986 (p<0.05) and more students 
intended to change behaviour due to STD risks in 1988 (p<0.01) (I). 
5.3.3 Differences correlated to age: Attheageof 16,51% of the healthy school 
girls who had been sexually active during the last month, reported use of OC and 
33% use of condoms (II). At the age of 18, more girls (77%, p< 0.05), reported 
OC use and fewer girls (13%, p< 0.05), reported use of condoms. Change of 
contraceptive method was most common among girls reporting the use of a 
condom at the age of 16. Thirteen of 18 girls using OC at their first visit were 
still using OC at their latest visit. However, only 4 of 21 girls using condom at 
their first visit were still condom users at the last visit (p<0.05). 
5.3.4 Differences correlated to the age of the sexual debut: Girls with an early 
coitarche had a tendency to continue having more unprotected coitus and to be 
less careful with condom or OC use than later debutating girls (III). 
5.3.5 Differences in the use of contraception correlated to sexual activity: 
An unprotected coitus was most common close to the sexual debut, independent 
of age (II; III). Condom use was most common close to the debut. A steady 
partner was a reason for testing OC, but compliance tended to be deficient, and 
unprotected coitus was a common result of interrupting OC use. 
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5.4 Knowledge and attitudes to sexually transmitted 
infections 
5.4.1 Sources ofinformations: In 1988, school was most frequently mentioned 
as the best source ofinformation among 18-19 years old boys and girls (34%) 
(I). The media were mentioned by 29% and other written material by 16%. In 
1989-1991 almost all 16 years old girls had heard about STD in school lessons 
(II). Most girls emphasized individual reading as the best source ofinformation, 
and a friend as the most common person for discussion. The sources were as 
follows: newspapers 93%, friends 91 %, boy-friend 84%, parents 41 %, and other 
adult 53%. Nearly half of the girls (47%), considered themselves insufficiently 
informed about STD; the corresponding figures for birth control methods and for 
pregnancy and abortion were 10% and 18% respectively. 
5.4.2 Changes overtime: Significantly more 18-19 year old students in 1988 
compared to 1986 had heard about STD in school lessons (p<0.001), were aware 
of veneral warts as sexually transmitted (p<0.001 ) and knew about important 
aspects of chlamydia infections (prevalence, symptoms, treatment and need of 
partner follow-up) (pO.OO1 ) (I). However in 1988 only slightly more than 50% 
knew that a chlamydial infection can be asymptomatic and only approximately 
25 % knew that chlamydia infections at that time were widely spread. S ignificant ly 
more students in 1988 admitted being concerned about the possibility of 
infections being transmitted during coitus (pO.OO1 ), and their fear of contracting 
STD was more common. More students had heard about STD in school 
education (pO.OOl) and more had spoken to their parents (pO.Ol) or another 
adult (p<0.01) about STD in 1988. More boys and girls intended to use or let 
their partner use a condom (p<0.001 ). No more students, however, mentioned the 
alternative to keep to one partner or to refrain from intercourse. 
5.4.3 Differences between boys and girls: The relative differences in knowledge 
and attitudes between boys and girls were equal in 1986 and in 1988 (I). Girls 
were better informed about STD than boys (pO.OOl) and girls had discussed 
STD with some other person more often than boys (pO.Ol). Boys were more 
willing to use a condom (p<0.05) but had less intention to keep to one partner 
(pO.OOl). 
5.4.4 Differences correlated to age: The healthy school girls were better 
informed when they were 18 years of age than when they were 16, with regard 
to chlamydia (pO.OOl), condylomata (pO.OOl) and gonorrhoea (pO.Ol) but 
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with regard to herpes they were still as confused as when they were at the age of 
16(11). 
5.4.5 Differences correlated to type of education: No difference in knowledge 
emerged between students taking part in theoretical or practical courses (I). 
5.4.6 Differences correlated to geographic area: There were no differences in 
knowledge between students from the urban or the rural area (I). 
5.4.7 Differences correlated to social background: No differences were seen 
(II). 
5.4.8 Differences correlated to sexual experience: Girls without sexual 
experience at the age of 18 were less informed about STD and STD protection 
(p<0.01 ) (II). The groups of healthy school girls (HSG) with more coital partners 
or an early sexual debut were more or as much informed as others. Girls who 
recently had coitus with a new partner without using a condom, and consequently 
ignoring the risk of STD transmission, were as well-informed as others. 
5.4.9 Attitudes to risks and risk behaviour: Both in 1986 and in 1988,4-5% 
of the boys and 8-9% of the girls with coitus experience had been treated for STD 
(I). The fear of contracting STD had a tendency to increase between the 2 
periods, particularly among boys, but girls were more worried than boys, both 
in 1986 and 1988. When evaluatingthe intention to protect one-self against STD 
most students asserted their intention to keep to one partner. The use of a condom 
was significantly more often favoured by those who had never had coitus 
(pO.OOl), but in 1988 a more positive attitude emerged among all pupils. In 
1988 significantly more respondents were worried about contracting STD and 
stated that this had influenced their behaviour. Nevertheless, in both 1986 and 
1988 only about 50% of the boys and 60% of the girls could give adequate 
reasons why STD must be controlled. Although about one third of the sexually 
experienced healthy school girls (HSG) acquired an STD during the 2-year 
fol low-up study, only 1 girl feared that she had been at risk of contracting an STD 
at her latest coitus (III). Two girls thought they might have given their partner 
an infection. The remaining girls were convinced they had neither acquired nor 
transmitted an infection at their latest coitus. Among girls with experience of 
condom use, al 1 mentioned contraception as the purpose of condom use and only 
half of them mentioned STD protection as a further reason. When the teenage 
girls were asked how they would try to avoid an STD, 8% mentioned the 
possibility of monogamy (II). 
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5.5 Chlamydia trachomatis, gonorrhea and human 
papillomavirus infections detected in the cervix 
5.5.1 Chlamydia trachomatis. In the FPYC group 36 women (12% of the 
sexually experienced women) were positive for the chlamydial test in 1986-1987 
(IV). In the HSG-group 2 girls (4% of girls with coital experience) were positive 
at the age of 16 (1989-1990) and 1 girl (1% of girls with coital experience) 2 
years later at the age of 18 ( 1991 -1992) (V). Another 2 positive tests were seen 
during the time for follow-up. No virginal girl in the FPYC or in the HSG group 
had a positive chlamydial test (IV;V). 
5.5.2 Gonorrhoea. All of the 36 women from the FPYC with positive 
chlamydial tests in 1986-1987 (CTP), had negative cultures for gonorrhoea (IV). 
5.5.3 Human papillomavirus infection. Virginal girls had neither HPV DNA 
in the cervix, measured by PCR, nor antibodies against HPV 16 or HPV33 in 
serum, as measured by ELISA tests (V). At the age of 16, 12% of the coitally 
experienced girls harboured HPV DNA in the cervix compared to 25% at the age 
of 18. HPV 16 and HPV33 were the most common types of virus DNA. Forty 
five percent of the girls found to harbour HPV DNA in the cervix had clinical 
signs of an infection, 10% had subclinical changes and 45% had no signs of 
infection. When following 32 chlamydia positive young women for a mean 
period of 15 months the cumulative number of patients with changes which could 
be related to a genitoanal human papillomavirus infection was 27 of 32 (either 
genital warts, koilocytosis in the PAP smear or colposcopic changes) (IV). At 
the last visit, 6 patients had cytologic atypia ( 18.8%). During the same 24-month 
period the prevalence of cytologic atypia in all smears, taken among women of 
the same age attending the clinic, was 1.5%. In 1986-1987, 9 of 284 screened 
FPYC women (3.2%), had koilocytosis in PAP-smears (IV). 
5.6 Serological evidence of HPV and herpes virus 
infections 
5.6.1 Human papillomavirus infection : No virginal girl had antibodies against 
HPV 16 or HPV3 3 in serum (VI). Of the coitally experienced girls, 7 ( 12%) had 
antibodies against HPV 16 and/or HPV3 3 in serum at the age of 16 compared to 
11 ( 14%) at the age of 18. Three girls had antibodies against HPV 16 at the first 
visit and another 7 girls seroconverted during the study. Four girls had antibodies 
against HPV33 atthe first visit. Another 4 girls seroconverted forHPV33 before 
the last visit. 
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The correlation between serum IgG against HPV16 and HPV33 and the 
number of coital partners at the age of 18 was calculated and gave an odds ratio 
(OR) of 16.3 (pO.OOl) if the girl reported more than one partner in life. 
5.6.2 Herpes simplex virus infection. At the first visit, at the age of 16,41 % 
of the women in the HSG group (VII) had antibodies in serum, due to an HSV-
1 infection, 24% of virginal girls compared to 51 % of sexually experienced girls 
(p<0.01). One sexually experienced girl was positive for HSV-2 antibodies. 
Four girls seroconverted for HSV during follow-up, 1 for HSV-2 and 3 for HSV-
1. None of the girls had ever had any clinical signs of a genital herpes simplex 
infection. No virus isolation tests were collected as no girl had any clinical 
manifestations of a genital herpes infection. 
5.6.3 Epstein-Barr virus infection. At the age of 16, 82% of 98 healthy school 
girls were seropositive for capsid antibodies against Epstein-Barr virus, 65% of 
the virginal girls and 92% of the sexually experienced girls (p<0.001 ) (VII). Six 
girls seroconverted during the 2 years of follow-up, 1 of them lacking sexual 
experience. 
5.6.4 Cytomegalovirus infection. No differences were seen between virgins or 
sexually experienced girls regarding prevalence of serum antibodies against 
CMV; 45% were seropositive at age 16 and 49% 2 years later (VII). The 3 girls 
who seroconverted during the time of the study were all sexually active. 
5.7 Multiple infections 
5.7.1 Dual types of HPV: Of 20 girls, tested positive forHPV-DNA in the cervix 
either at the first or second examination, 5 (25%) were simultaneously tested 
positive for dual types, showing combinations as follow: HPV 16-6/11, HPV 16-
18, HPV 16-31, HPV 18-31, HPV31 -33 (V). One girl was seropositive for both 
HPV 16 and HPV33 when the study started and another girl seroconverted for 
both HPV 16 and HPV33 during the study (VI). There is no serological test 
available, that is type-specific for the other types of HPV. 
5.7.2 HPV and CT: In the 32 young women followed up for a chlamydial 
infection (IV), 15 women had clinical or subclinical changes directly connected 
to a GPVI: 8 were found to have condyloma acuminata, 8 had morphological 
changes pathognomic for HPV (koilocytosis), and 6 had vaginal cytological 
atypias (4 women CIN 1,2 women CIN II). A further 9 women had colposcopic 
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features or acetowhite areas, non-specific for a HPV infection. Only 5 women 
were free from all clinical or subclinical signs of a HPV infection. In the group 
of healthy school girls (V) the incidence and prevalence of chlamydia infections 
was very low. Of 5 girls treated for a chlamydia infection before the last visit, 
3 girls had signs of a GPVI at the last visit: 1 was found to harbour HPV DNA 
in the cervix, another one had developed antibodies against HPV 16 and 33 and 
she also had an atypical smear. The third girl had an atypical vaginal smear. 
5.7.3 There was no covariance seen between the occurence of different herpes 
viruses, that is between the occurence of HSV, EBV and CMV (VII). 
5.8 Persistence of infections or reinfections 
5.8.1 Chlamydia trachomatis: During 15 months offollow-up after treatment 
of a cervical chlamydia infection, 7 of 32 women were found to be chlamydia 
positive for a second time (IV). All 3 2 women were tested negative 1 month after 
treatment, and these 7 women were considered to have been reinfected. During 
24 months of follow up in the group of healthy school girls, none of the 4 teenage 
girls who had been infected with chlamydia trachomatis once, tested positive 
again (V). 
5.8.2 Human papillomavirus: At the age of 16,6 of 52 sexually experienced 
girls were found to harbour HPV-DNA in the cervix (V). Three of 6 girls had 
became HPV DNA-negative at follow-up. Two girls harboured HPV 16 and both 
girls tested positive to the same HPV type at the next examination 2 years later. 
A third girl, harbouring HPV31 at the first visit, was still harbouring HPV31 at 
the last visit. However, we were unable to determine whether these girls had a 
reinfection or a persistent infection. 
5.9 Factors influencing the frequency of infections 
5.9.1 Sexual experience: Nobody without coital experience was found to 
harbour either a chlamydial infection or HPV-DNA in the cervix (IV;V), 
indicating that cervical chlamydial or human papillomavirus infections in 
teenage girls are exclusively sexually transmitted. Furthermore none of the 
virginal girls had serum-IgG against HPV16 or HPV33 (VI). Girls found to 
harbour HPV DNA in the cervix or being seropositive for HPV 16 or HPV 33 had 
been sexually active for a longer time. 
Significantly more sexually experienced girls had antibodies in serum against 
HSV-1 and Epstein-Barr virus (VII). Only 2 girls had antibodies against HSV-2, 
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both of them were sexually active. No difference due to sexuality was seen 
regarding the prevalence of serum antibodies against CMV, but all 3 girls 
seroconverting during the follow-up were sexually active. Significantly more 
virginal girls were at the same time lacking antibodies to HSV, EBV and CMV 
(p<0.01). 
5.9.2 Contraceptive methods: No differences in contraceptive habits were seen 
between infected girls and others (II; V; VII). Consistent condom use was 
uncommon and OC:s as well as condoms were temporarily used by the majority 
of the evaluated girls. 
5.9.3 Number of partners: More than 4 coital partners implied a significantly 
increased risk for harbouring HPV DNA in the cervix (V). A greater number of 
coital partners was associated with seropositivity to HPV 16 and/or HPV33 
(VI). Chlamydial infections were too few to illustrate any possible connections. 
Girls seroconverting for HSV-1, HSV-2, CMV and EBV during the study were 
all but 1 EBV seroconverting girl sexually active but reported no more coital 
partners than other girls (VII). 
5.9.4 Age of sexual debut: Girls with an early coitarche, defined as a sexual 
debut before the age of 15, reported more episodes of STD (p<0.05) than girls 
with a later coitarche and they were found to have more cytological atypias than 
the remaining girls (p<0.05) (III). Of 5 girls, positive for the chlamydial tests 
sometime during the study, 4 had an early coitarche (p<0.05) (V). Of 20 girls 
with HPV DNA in the cervix at the beginning or end of the study, 7 girls had a 
coitarche before the age of 15 (NS), and of 16 girls with serum-IgG against 
HPV 16 and/or HP V3 3,8 girls had an early coitarche according to our definition 
above (p<0.02) (VI). Of 17 girls with an early coitarche, 5 had no signs of a 
chlamydial or a HPV infection compared to 42 of 55 later debutating girls 
(pO.OOl). No differences in seroconversion against the herpes group viruses 
could be related to age of coitarche. (VII). 
5.9.5 Time since coitarche: At the age of 18,17 girls were HPV-DNA positive 
in the cervix, 16/52 of the girls with more than 2 years since coitarche and 1/15 
with less than 2 years since the debut (NS) (V). All 11 girls seropositive for 
HPV 16 or HP V3 3 at the age of 18, had been sexually active for more than 2 years 
(VI). 
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5.10 Clinical and subclinical appearance 
As mentioned above, among the 32 young women followed up for a chlamydial 
infection (IV), 15 women had at some time clinical or subclinical changes 
directly connected to a GPVI: 8 were found to have a clinical diagnosis of 
condyloma acuminatum , 8 women had subclinical morphological changes 
pathognomic of HPV (koilocytosis), and 6 had cervical cytological atypias (4 
women CIN 1,2 women CIN II). Among the healthy school girls (V), 5 girls had 
genital warts some time during the follow up, and 4 of them harboured HPV 
DNA in the cervix. It is notable that 4 of 5 girls with a chlamydial infection in 
the cervix had signs of an infection. Only 39% of the healthy school girls, 
independent of coital activity or not, never reported symptoms from the genital 
sphere during the time for follow-up (III). Vaginal discharge was the most 
common complaint followed by dysmenorrhea, vaginal irritation, abdominal 
pain and irregular bleeding. 
In the group of chlamydia-positive women followed for 15 months, all had 
a transformation zone accessible for colposcopy (IV). The appearance varied 
from time to time. All women with cytological or histological signs of koilocytosis 
or dysplasia had changes in the colposcopic evaluation. In the FPYC group 3% 
had koilocytosis in the smear. 
5.11 Social background and life-style factors influencing 
reproductive health 
The SQ-group was not examined regarding social background factors. Living in 
an urban or rural district, however, did not influence the level of knowledge or 
attitudes (I). In 1988 more 18-19 years old girls resident in the rural area than 
in the city had had their sexual debut (87% vs 74%, p<0.01). 
In the group of HSG, no significant differences were seen in the level of 
knowledge, attitudes, or in the time for coitarche, when considering social 
background factors in general, or the time for coitarche (II). However, girls from 
large families, or girls leaving their parental home at a younger age, were over-
represented in the group of girls having had their coitarche before the age of 15 
(III). Life-style factors such as smoking and drinking alcohol also correlated to 
the time of coitarche (III). Girls with an early coitarche preferred to have their 
first child at 22 years of age at the earliest, other girls about 1 year later. 
However, the girls with an early debut seemed to worry less about getting 
pregnant with passing time (p<0.05) and were at age 18 years less worried than 
the other sexualy experienced girls (p<0.05). On the contrary, they were more 
worried about their future fertility than becoming pregnant (p<0.001 ). This was, 
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however, also the case for the other sexually experienced girls (p<0.05). There 
were no significant differences between groups concerning plans for their future 
occupation but more of the girls with an early coitarche were planning for a 
future education (p<0.05). No prominent differences were seen according to the 
girls' appreciation of themselves, regarding mood, wellbeing or relations. 
However, there was a tendency to less ense of satisfaction among virginal girls 
at the age of 18. 
No evident differences were seen in the prevalences of HPV DNA in the 
cervix (V) or antibodies to either HPV (VI) or the herpes-group viruses (VII) 
with regard to socioeconomic background. 
6. DISCUSSION 
6.1 The studied group - selection, reliability and validity 
This thesis is based on studies among teenagers and young women living in 
Värmland, a county in the mid west of Sweden. Karlstad is the largest town in 
Värmland (80.000 inhabitants), situated in the more densely populated south 
part of the county, and Torsby is a small municipality of a rural district ( 15.000 
inhabitants) situated in the more sparsely populated northern part. 
The first study (I) describes the conditions among 18-19 year old girls and 
boys ready to leave upper secondary schools in Karlstad and Torsby. The study 
compares sexual experience, knowledge and attitudes between boys and girls, 
between students from practical and theoretical classes and between students 
living in densely or sparsely populated regions. At the time for the study about 
90% of all teenagers completed their upper secondary school and they are 
represented in this study. 
The second study (IV) emanates from young women visiting the Family 
Planning Clinic or the Youth Clinic in Karlstad. Most of them were sexually 
experienced, coming for a special purpose, mainly contraceptive advice. 
The third study (II; I; V; VI; VII) emanates from 15-17 year old girls, starting 
their upper secondary school education in a health care program. They were 
invited in school to take part in a gynecological health control study. It was 
emphasized that all girls were welcome to participate, girls without sexual 
experience as well as sexually active girls. Our purpose was to come in contact 
with girls close to the time of their sexual debut. The study meant a rather 
substantial undertaking for the committed girls. 
The first and second study describes the conditions in 1986-1988 and the third 
study took place in 1989-1993. In spite of different groups and different time 
periods, the data about sexuality are very similar in the 3 groups, indicating no 
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large divergencies from the underlying population. As reported earlier by Lewin 
(1984) and Traeen & Lewin (1992a), we found only a minority of the girls 
reporting many partners. On the other hand it is possible, as postulated in paper 
II, that girls, already sexual experienced at the start of the study, may be slightly 
overrepresented in the group of healthy school girls. The contraceptive use 
reported by the healthy school girls may also have been influenced by the fact that 
the girls had very good access to contraceptive advice. The girls may even have 
had better knowledge about STD and STD-protection because of their special 
type of education, and even participation in this study may have contributed to 
better information. Consequently, the contraceptive habits and knowledge and 
attitudes are not meant to be compared to other studies but o be correlated to the 
other examined factors of the group, in order to correlate knowledge and attitudes 
to actual behaviour. However, the distribution of contraceptive methods, does 
not differ from figures given by Brännström et al ( 1991 ), evaluating contraceptive 
habits among 15-19 years old girls in a community-based study in another region 
of Sweden. It is also a distressing observation from our study that the girls in spite 
of very good access to contraceptive advice had a rather low compliance both for 
OCs and condoms. 
Different techniques have been used to collect data. In the first study (I) the 
students answered a self administrated questionnaire during a lesson. The 
questionnaires were all carefully answered and returned without any indecent 
notes, indicating serious participation. The project was an isolated investigation 
and not connected to any efforts to improve teaching. In the second study (IV) 
the women were interviewed by 1 of 3 midwives, and if they were found to be 
chlamydia-positive, they were later interviewed by the same doctor on 3 
occasions. In the third study (II; III; V; VI; VII) the girls were repeatedly 
interviewed by the same doctor with some recurrent questions mixed with 
additional questions. The questions concerned social life, sexuality and 
contraceptive habits. The questioning was performed without access to answers 
given earlier. Moreover, the girls filled in questionnaires about knowledge and 
attitudes to sexuality and sexually transmitted diseases and assessed their 
feelings and self-apprehension using a ten-point visual analogue scale (VAS). 
Davioli et al ( 1992) have described the risks of under-reporting if interviewing. 
We, however, found a very good correspondance between answers given by 
interviews and by questionnaires and at different times, indicating a good 
reliability. 
The fact that all interviews, gynecological examinations and sampling were 
performed by the same doctor, probably facilitated homogeneous performance 
and assessment. A longitudinal study demanding 5 consecutive visits and 
including discussions about issues making inroads on integrity, necessitates a 
trustful cooperation. It is our opinion that we attained such a confidence-
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inspiring atmosphere. Hornberger et al (1995) reported teenage girls being 
generally accurate in reporting sexual history information, which is in accordance 
with our opinion. The intention was to ask questions in a neutral way, not giving 
the responders the impression that they ought to say the "right" answer. Aral & 
Cates have in a paper from 1989 discussed the difficulties of obtaining validated 
sexual behavioural measures. They have pointed out the inconsistency, the 
complexity and risk of translating separate variables into general indicators of 
sexual behaviour, and of generalizing to the total sexually active population from 
data based on specific age groups. 
This thesis specifically focuses on teenagers as a special group with regard 
to sexual behaviour as well as psychological, social and biological conditions. 
The contraceptive compliance rate was rather low and during the follow up time 
of 2 years, most teenage girls had experienced use of OC, as well as use of 
condoms mixed with unprotected coitus. This makes any conclusions of infection 
rates due to contraception habits impossible. 
The gynecological examination was performed in a fixed manner, carefully 
avoiding the risk of contamination when sampling, i.e. by using brushes, object 
glasses and exam ination utilities wrapped and not stored in the exam ining room. 
The laboratory process also was done in a careful way, avoiding contamination. 
The serum samples and the tests for HPV DNA, chlamydia and PAP-smear were 
all sent to divergent laboratories as described above, and neither the sexual data 
nor any results from the other analyses were available. 
This thesis is based on studies from a limited area of Sweden and can in some 
respects reflect local circumstances. The very low recognition of the Venereal 
Disease Clinic, observed in the first study, may reflect such a local fact. 
However, our main conclusions about knowledge, attitudes and behaviour have 
been reproduced in several other surveys in Sweden (Andersch & Milsom 1982; 
Brännström et al 1991; Tydénetal 1991b; Milsom et al 1991; Persson 1992a, 
1992b; Klanger et al 1993; Larsson et al 1996) as well as in a neighbouring 
country (Traeen 1992b; Kraft 1993). 
6.2 The diagnostic methods and their restrictions 
The only feature specific of HPV infection without dysplasia is condyloma 
acuminatum (Barasso et al 1992). Colposcopy allows the evaluation of the 
extent of a lesion and the localization ofthe squamo-columnar junction. In young 
women the transformation zone is mostly accessible. As shown by Schneider et 
al (1988) and Spitzer et al (1990), colposcopy is very sensitive, but has a 
substantially lower specificity. If colposcopy is routinely performed, it has been 
reported that about 80% of the atypical transformation zones are found to 
correspond histologically to a benign acanthotic non-glycogenated squamous 
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epithelium (Wespi 1986) which represents metaplastic epithelium without any 
atypical potential (Barrasso 1992). In the light of these facts it should be 
observed that some ofthe girls considered to have a GPVI in the follow-up study 
of the chlamydia positive women (VI) may have been free from an infection. 
Schneideretal (1988) suggested that all acetowhite epithelia with minor changes 
showing histological features of mature metaplasia could represent early or 
discrete HPV-associated lesions. However, Barasso et al (1991) found HPV 
DNA sequences in only 13% of such epithelia. It is still a thought-provoking fact 
from our research, that 6 of 32 women (19%), had an atypia 15 months after 
treatment for a chlamydial infection. The results of the colposcopy in the later 
longitudinal study, were only used to determine when and where to take a biopsy. 
The biopsies were taken at the last visit and have subsequently not influenced the 
results. 
One of the girls who tested positive for HPV33 DNA in the cervix developed 
antibodies to HPV33 first 18 months later, suggesting a slow development of 
antibodies. Only 1 of the 5 girls, tested positive for HPV33 DNA in the cervix 
atthe last visit had simultaneous antibodies against HPV33, further suggesting 
a slow antibody response or suggesting a low sensitivity of the assay. HPV 16 
DNA in the cervix, however, gave a faster and much more frequent occurence 
of HPV 16 antibodies in serum. Seroconversions coinciding with HPV 16 DNA 
acquisition have also been reported before (Wikström et al 1995). Discordance 
between the type of HPV DNA found in the cervix and the specific antibody 
response may be due to several factors: multiple infections, cross reacting 
antibodies, or an "original antigenic sin phenomenon", i.e. the inclination to 
primarily respond against a similar, earlier familiar type of virus, when being 
exposed to a new related type of virus (Hoskins 1976). 
Samples for PCR (V) were taken using a cytobrush which provides a sample 
of chiefly superficial cells. Thus the cytological method may be less sensitive 
than a histological method to btain cells from a deeper layer of basal cells. Any 
virus DNA detection method is dependent on a representative sample being taken 
and we can thus not exclude the possibility that HPV DNA negative women may 
have had an infection at a site not sampled (V). However, the good correspondance 
between HPV 16 DNA in the cervix and the HPV 16 antibody response (VI), 
indicates that most HPV 16 infections were detected. 
As nobody during the follow up reported any signs of a genital HSV infection, 
no girl was evaluated. It remains an interesting field to determine the prevalence 
of HSV as well as EBV and CMV in the genital tract of healthy teenage girls and 
to compare their presence to sexual background data. 
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6.3 Epidemiological comments 
Genital chlamydia trachomatis infections and human papillomavirus infections 
were exclusively present in sexually experienced girls, and in particular the 
prevalence of HPV in the cervix rose quickly after coitarche. It is in general 
hazardous to compare prevalences of infections between independent surveys. 
The population as well as the methods vary. However, in general one can 
constitute, that the prevalence of chlamydia trachomatis infection among young 
women decreased in Sweden during the second half of the eighties (Thej Is et al 
1991; Persson 1993). In Karlstad the reduction was about 75% (Andersson-
Ellström 1993). This tendency is reflected in this thesis where the chlamydia 
screening group in 1986-1987 had 12% chlamydia (IV) and the healthy 
schoolgirls about 5 years later had a chlamydial prevalence of 4-1 % (V). During 
the second study (IV), this infection was not yet included in the legislation for 
STD, and some of the reinfected women were reinfected due to their steady 
partner who had not accepted any treatment. 
HPV colonisation, when compared to the colonisation of HSV-2, seems to 
take place closer to the sexual debut, at least in early debutating girls. This could 
reflect the actual spread of the organism in the population, the property of the 
infectious agents, special patterns of sexual behaviour and/or biological age-
dependent conditions (Moscicki et al 1989). 
Different studies, using the PCR technique, have reported a prevalence of 
HPV DNA in the cervix of 20-50% in young women (Ley et al 1991, Bauer et 
al 1991, Wheeler et al 1993). As mentioned before, a major difficulty when 
analysing the results, is to establish comparisons between studies. The healthy 
school girls represent a very young group, being about 16 years old at the first 
examination. Strand (1995) reported a 16% prevalence of HPV DNA in the 
cervix of sexually experienced 14-19 year old Swedish girls and Evander et al 
( 1995 ) reported 21 % HPV DNA positi vity in a cohort of 19-25 year old sexual ly 
active Swedish females. In a gynecological health control material from women 
younger than 3 0 years, Hagmar et al ( 1995 ) reported 16% HPV DNA positivity. 
In another Swedish routine gynecological health control material in women aged 
20-29 years, Hansson et al ( 1993 ) reported 13 % HPV DNA positivity. Syrjänen 
et al (1990) reported a HPV prevalence age peak in women between 20 and 24 
years. However, already 16/52 (31%) of our 18 years old girls, with at least a 
period of 2 years since coitarche, carried HPV DNA in the cervix. This indicates 
that the peak reflects a short time interval since coitarche. If non-sexual spread 
of HPV genital infections in teenage girls can be excluded, this makes it possible 
to determine the incidence of infection close to the sexual debut. 
As in other studies (Bauer et al 1991; Hansson et al 1993; Hellberg et al 
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1995), HPV 16 was the most common type of human papillomavirus, found in 
the cervix. HPV33 was more prevalent than previously published (Moscicki et 
al 1990; Bauer et al 1991 ; Hansson et al 1993 ; Hellberg et al 1995). The presence 
of HPV 6 in the cervix was uncommon in our teenage group, at variance with the 
theory that the lower share of HPV6 among older women is due to a lower 
tendency of persistence of this infection (de Sanjose et al 1992). 
The time trend data for occurence of a HPV infection has been estimated to 
describe a viral "survival curve", suggesting a rather steady disappearance of 
viral infection over the 9-30 months of observation (Schiffman 1994). If the 
infection persists, it can predispose to CIN and cancer (Morris et al 1995). 
Among our teenage girls (V), 3 of 6 girls infected at the age of 16, harboured the 
same type of HPV (HPV 16 in 2 cases and HPV31 in 1 case), at the second time 
of sampling, 18-24 months later. However, a reinfection with the same type of 
virus cannot be fully excluded, and the figures are small. As the propensity for 
infection to persist is considered to be a prerequisite for the development of 
cervical cancer (Morris et al 1995), it will be a continued challenge to follow the 
natural history of early acquired persistent genital human papillomavirus 
infections in this population. 
We found some dual infections (3/6 at the age of 16, and 2/17 at the age of 
18). The PCR technique may allow more dual infections to be detected, due to 
its higher sensitivity compared to other HPV DNA techniques. Multiple infections 
have been reported to be associated with an increased risk of cytologically 
evident low grade CIN (Morrison et al 1991; Schiffman et al 1993). Our 
population is too small to estimate this. One of 3 girls with multiple HPV types 
at the first visit had a mild atypia at the last visit. 
One of the most important original findings of this thesis are the results 
concerning the association between cervical HPV DNA and the appearance of 
serum antibodies against HPV 16 and HPV33, and the absence of both in virginal 
girls. The strength ofthis study isthe longitudinal approach and the participation 
of women close to their sexual debut. The serological markers support sexual 
transmission, and the coexistence of HPV DNA in the cervix and antibodies in 
the serum confirm the sensitivity and the specificity of the tests. However, as 
mentioned above, the HPV3 3 antibody reaction had a curious pattern, either due 
to a low sensitivity of the test, or to a slow or transitory antibody response. Only 
2 of 8 girls with an antibody response against HPV 33 were shown to harbour 
HPV33 in the cervix. A further 3 HPV33-seropositive girls had HPV DNA of 
other types in the cervix. 
Three percent of the young women attending the Family Planning Clinic or 
the Youth Clinic (IV), hadkoilocytosis in their PAP smears in 1986. Mitchell et 
al (1986) reported that cytological evidence of subclinical HPV infection 
(koilocytosis) in PAP smears in women younger than 25 years, when followed 
36 
prospectively over 6 years, revealed a RR of 38.7 for the development of CIN 
III compared to the general population. Jones et al (1984) found the same 
distribution of CIN I, CIN II and CIN III in adolescents with abnormal PAP 
smears as in the adult population except that no invasive carcinoma was found 
in the adolescents. Recently it has been questioned if there is a continuous 
development through ASCUS, CIN I, CINII, CIN III and cancer (Kiviat et al 
1992). A new Bethesda classification (1989) has included the possibility of low-
grade and high-grade squamous intraepithelial lesions (LSIL contra HSIL 
including CIN II and CIN III) to represent distinct entities with a different 
potential for progression. So the importance of CIN I or atypical cells of 
undetermined significance (ASCUS) still has to be questioned. In the teenage 
group (V), only 1 girl had CIN II, all the others had atypias classified as CIN I.In 
the chlamydia positive group (IV), 2 of 6 women with an atypia had CIN II. 
The association between a chlamydial infection and the appearance of 
vaginal cytological atypias has to be further evaluated. The high frequency of 
atypias in the group of young women followed for 15 months after a chlamydial 
infection (IV), is an important observation. The frequent occurence of clinical 
or subclinical signs of a HPV infection supports the possibility of chlamydia as 
an up-regulating factor for HPV replication (von Krogh 1991 ), or that the cervix 
becomes more susceptible to infection (Moscicki et al 1989; Wahl 1984). It is 
still possible, but not yet convincing, that, besides HPV, a concurrent infection 
may act as a co-factor in the development of a cervical cancer (Piura et al 1985). 
In the longitudinal 2-year follow-up study the prevalence of chlamydial infections 
was low, thus inhibiting further investigation of this hypothesis (V). 
The increased exposure of cervical columnar epithelium in adolescent girls 
is believed to increase the probability of Chlamydia trachomatis infection among 
those exposed to the organism (Stamm & Mårdh 1990). The immature cervix as 
a locus minoris resistentiae has by some authors been proposed to lead to more 
atypias (Gottardi et al 1984;Robbeyetal 1984; Moscicki et al 1989). Girls with 
an early coitarche had more cervical atypias (III). We even found that teenage 
girls, with 1 year or less between menarche and coitarche, had more atypical 
smears compared to other sexually experienced girls (unpublished data, p=0.05, 
Fishers test). Peters et al ( 1986) have found some evidence that subjects with a 
short interval between menarche and initiation of sexual intercourse were at an 
elevated risk for invasive cervical cancer, but Brinton et al (1989) could not 
confirm this effect. 
The link between the prevalence of antibodies against EBV and sexual 
experience (VII) also has to be further investigated. EBV plays a role in the 
etiology of nasopharyngeal squamous epithelial carcinoma (Zur Hausen et al 
1970; Nonoyama et al 1973). Taylor et al (1994) found, using PCR and 
cytological samples from the cervix, that 40% of women harboured EBV in the 
37 
cervix, but there was no increased prevalence among women with abnormal PAP 
smears. On the other hand, Landers et al (1993) found EBV with increasing 
frequency in CIN II, CIN III and carcinoma of the cervix uteri. EBV DNA has 
been found in 48% of women when cells were sampled from acetowhite 
koilocytotic vulvar lesions (Voog et al 1994). The role of EBV has to be further 
evaluated. 
The association between an early debut and a tendency to more sexual 
partners makes the research of the immature cervix as a risk factor more 
complicated. The further complex coexistence of smoking and STDs (Rahm et 
al 1991 ), makes the causal connections difficult to evaluate. Smoking was more 
common among girls with an early coitarche and there was a tendency to more 
smoking among girls harbouring HPV DNA in the cervix. Smoking not only 
corresponds to sexual behaviour but may even increase the susceptib lity of the 
uterine cervix to infectious agents and carcinogens (Holly et al 1992; Hellberg 
et al 1986 and 1988). Barton et al (1988) demonstrated that HPV 16 infection and 
cigarette smoking each led to a decrease in the cervical epithelium number of 
Langerhans 'cells, an important component of cellular immunity. 
In addition it is also necessary to consider the male factor. Are early 
debutating women exposed to men, more likely to transmit infections? (Opaneye 
& Willmott 1991 ). This study has mainly focused on girls and young women and 
the importance of the male partner has to be further evaluated. Do very young 
girls to a greater extent have intercourse with older more experienced partners, 
and is casual sex by these men more common? (Traeen & Lewin 1992a). Our 
girls with an early coitarche reported more sexual partners than "boyfriends" and 
reported more often an isolated first intercourse, indicating a casual contact. 
Sexual experience does not obviously mean actual sexual activity, and 
behaviour may be inconsistent. O'Reilly & Aral (1985) pointed out that the use 
of indicators of sexual experience rather than indicators of sexual activity, will 
both overestimate the teenage population at risk and simultaneously underestimate 
the age-specific rates of STD. In our studies an early coitarche coincided with 
a continued higher sexual activity. The inconsistency of contraceptive use, in 
spite of good accessibility, has been evidently demonstrated. Decreased use of 
condoms among girls with many partners and among girls with casual sex has 
previously been reported by Kraft et al (1990), Tydén et al (1991a), Traeen et 
al ( 1992b) and Dickson et al ( 1993 ). The primary reason for contraception being 
birth control and not STD protection has likewise been described by Traeen et 
al (1992b). 
Self-efficacy has been suggested to be an important determinant of 
contraceptive behaviour. Heinrich ( 1993 ) has postulated an association between 
adequate contraceptive behaviour and factors of self-efficacy. It would be an 
interesting challenge to incorporate such measurements when further evaluating 
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the behaviour of Swedish teenagers. This is an obvious challenge, created by our 
results, where we have reproduced and confirmed the findings reported by Di 
demente et al (1993) and Zimet et al (1993), that a higher level of knowledge 
not necessarily leads to more adequate behaviour. Knowledge about STD and 
STD prevention correlated positively to sexual experience, indicating that 
subjects with experience, were more perceptive and learned more. They were, 
however, not able to uti lise this knowledge practically in their efforts to manage 
their own situation. The lower level of knowledge in boys may be an effect of 
them being less sexually experienced and maturing later. 
An early sexual debut was in our studies associated with an early menarche 
(III). Environmental stress has been suggested to trigger an early menarche 
(Belsky et al 1991 ), supporting the suggestion that a connection between early 
menarche and early coitarche in part may be dependent on social and psychological 
factors. Social background has been postulated by several authors (Hein 1989; 
Leslie-Harwit & Meheus 1989; Lidegaard & Helm 1990; Forrest 1994; Tyrer 
1994) to be an important factor for the determination of age of coital debut and 
for the consequences of sexual activity. However our studies, as well as studies 
by Sundet et al (1989, 1992) and Traeen & Lewin (1992a) among Norwegian 
teenagers have failed to find any association. Those of our own studies focusing 
on social background factors, however, emanate from a selected group of girls, 
all students of the same scho l. This may have tended to erase the differences. 
In addition, in countries like Sweden, characterized by a wide-spread welfare 
system, social background factors, only measured by the occupations of the 
parents, may be too blunt an instrument, and may not accurately indicate the true 
fam i ly s ituation. In such countries 1 ife-style factors have been suggested to have 
a greater relevance. We found that an early sexual debut and a risky sexual 
behaviour in teenage girls related to other life-style factors such as smoking and 
alcohol drinking as reported by Kraft ( 1991 ) and Traeen & Lewin ( 1992a). We 
thus adhere to the concept proposed by Berg-Kelly (1991), that teenagers 
perceived as older, may be at a greater risk with regard to their future health. 
To summarize, the young age of the studied population, the reliable sexual 
data, and the 2 years of follow up, has made it feasible to demonstrate some 
interesting events, related to sexuality. As far as we know, the observation that 
antibodies against HPV 16 and HPV33 in teenage girls are correlated to the 
occurence of HPV DNA in the cervix, and not found among virginal women, was 
shown for the first t ime in the world by us (Andersson-Ellström et al 1994). 
These results have later been reproduced in other surveys by Dillner et al 
(unpublished data) and Wideroffetal (unpublished data). The findingthat HPV 
serology was so strictly specific for sexually transmitted HPV has opened new 
possibilities for elucidating the etiology of cervical cancer by seroepidemiological 
studies where the dependence of concomitant infections, such as chlamydia 
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trachomatis as well as the herpes viruses HSV, EBV and CMV, and the role of 
the immature cervix and of smoking can be evaluated. 
7. SUMMARY AND CONCLUSIONS 
/'. Young people had reasonable knowledge about STD, at least about 
chlamydial infections. Knowledge increased during the eighties. 
ii. Girls were better informed about STD than boys. 
Hi. Knowledge about STD and STD protection among teenage girls correlated 
to sexual experience. 
iv. Risk behaviour was independent of the level of knowledge. 
v. Amongteenage girls, an early sexual debutwas associated with continued 
risk behaviour regarding reproductive health as well as the consumption 
of tobacco and alcohol. 
vi. An early sexual debut occurred more often in girls with an early 
menarche or with several sisters and brothers, and it tended to be more 
frequent in girls with older friends, indicating that girls who were 
perceived to be older than their biological age were at a greater risk. 
vii. There were indications that a genital chlamydia trachomatis infection 
increased the risk for a HPV manifestation and hence cervical 
intraepithelial neoplasia. 
viii. HPV-DNA in the cervix detected by PCR, occurred only in girls having 
hadpenetrating sex, but was common already a couple of y ear s after the 
sexual debut, and the frequency correlated to the number of coital 
partners. 
ix. HPV16 DNA acquisition in the cervix uteri was followed by a 
seroconversion of antibodies against HPV16 in most cases. 
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x. Antibodies against HP VI 6 and HP V33 in serum occurred only in girls 
who had had penetrating sex and was correlated to the number of sexual 
partners, indicating that non-sexual acquisition of these viruses is rare, 
if it at all exists in teenage girls. 
xi. Antibodies to HSV-1 and EBV correlated to the sexual debut, probably 
in part due to the close association between sexual activity and kisses; 
Further studies are necessary to evaluate the frequency and mode of 
transmission of HSV-1 and EBV to the cervix. 
xii. During the first years after the sexual debut, HP V was the most common 
sexually transmitted agent of those tested. 
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APPENDIX 
The questionnaires are too extensive to be published, but can be ordered from Agneta 
Andersson-Ellström, Gyn.mottagningen, VC Gripen, Box 547, S-65112 Karlstad, 
Sweden. 
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